使い捨て灌流用品の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、処置、予測（～2033年）

老年人口の増加と弁膜変性症が、使い捨て灌流用品市場の主な促進要因となっています。心血管疾患の有病率の増加とライフスタイルの変化が、予測年間における市場成長を促進する見込みです。

当レポートでは、世界の使い捨て灌流用品市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの使い捨て灌流用品と進化する競合情勢

• 主な業界動向の考察
• 使い捨て灌流用品市場のセグメント別の年間収益と市場の見通し（2015年～2033年）
• セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 使い捨て灌流用品市場のSWOT分析
• 使い捨て灌流用品市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Terumo Corp
• Abbott Laboratories
• Medtronic Plc
• Getinge AB
• LivaNova Plc
• Nipro Corp
• Eurosets Srl
• Senko Medical Instrument Manufacturing Co Ltd
• Edwards Lifesciences Corp
• MicroPort Scientific Corp
• Abiomed Inc
• Braile Biomedica Ltda
• Fresenius SE & Co. KGaA
• その他

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Perfusion Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Perfusion Disposables market for the year 2020 and beyond. Increase in aging population and valvular degeneration are major driving factors of the Perfusion Disposables market.

Growing prevalence of cardiovascular diseases and lifestyle changes is expected to drive market growth in forecast years. Valvular stenosis occurs when the heart valve narrows, restricting the blood flow across it. The narrowing of the valve causes the heart to work harder to supply adequate amounts of blood to the body and can cause heart failure. However, Valvular Regurgitation occurs due to leakage of blood through the valve, even when the leaflets are closed, or reverse flow of blood as the valve is closing. As a consequence, the heart supplies reduced volumes of blood.

Congenital heart defects, the most common type of birth defects, disrupt the normal flow of blood through the heart. patients suffering from coronary heart diseases (CHD), which results in insufficient blood supply to the heart, can be treated surgically through a CABG procedure. There are two basic ways of performing CABG procedures: On-pump and Off-pump CABG.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Perfusion Disposables and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Perfusion Disposables market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Perfusion Disposables market.
• Competitive dynamics insights and trends provided for Perfusion Disposables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Terumo Corp, Abbott Laboratories, Medtronic Plc, Getinge AB, LivaNova Plc, Nipro Corp, Eurosets Srl, Senko Medical Instrument Manufacturing Co Ltd, Edwards Lifesciences Corp, MicroPort Scientific Corp, Abiomed Inc, Braile Biomedica Ltda, Fresenius SE & Co. KGaA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Perfusion Disposables marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Perfusion Disposables market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Perfusion Disposables market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Perfusion Disposables market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Perfusion Disposables market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable